glp-1 stomach paralysis lawsuit in louisiana kentucky gastric intestinal obstruction semaglutide attorney semaglutide diarrhea law firm kentucky semaglutide gastrointestinal obstruction lawyer Wegovy® kentucky glp-1 gastrointestinal obstruction law – Partially paralyzed Marshfield woman finds

Total commercial health plan spending on the drug class more than tripled from 2021 to 2023

Most other intrinsic stem cell regulators do not meet this high bar of equivalence to the niche-defective phenotype

Sue Down over 60 lbs

It contains Levo-carnitine which is a type of amino acid (made from the amino acids lysine and methionine)

A 2023 meta-analysis of GLP-1 therapy found that patients experienced average visceral fat reductions of 18% over 52 weeks, with corresponding improvements in hepatic steatosis (fatty liver disease) and insulin resistance scores

That's a weight-loss drug demonstrating outcomes beyond the scale, in one of the highest-risk populations in medicine